FrancophonIA/ELRC3.0 huggingface dataset:
English: This reduces the risk of contamination, infection, leakage of insulin, blocked needles and inaccurate dosing.
Croatian: Time se smanjuje rizik od onečišćenja, infekcije, istjecanja inzulina, začepljenja igala i pogrešnog doziranja.
English: Pull the needle out of the vial.
Croatian: Izvucite iglu iz bočice.
English: Filling the pump
Croatian: Punjenje pumpe
English: Close glucose monitoring is recommended and the insulin dose should be adjusted on an individual basis (see section 5.1 and 5.2).
Croatian: Preporučuje se pomno praćenje razine glukoze, dok je dozu inzulina potrebno individualno prilagoditi (vidjeti dijelove 5.1 i 5.2).
English: Do not freeze During use: Do not refrigerate.
Croatian: Ne zamrzavati Tijekom uporabe: Ne odlagati u hladnjak.
English: Reaction at administration site: Local reactions at the place you inject yourself may occur.
Croatian: Reakcije na mjestu primjene: Na mjestu injiciranja mogu se javiti lokalne reakcije.
English: For intravenous use, it should be used at concentrations from 0.5 unit/mL to 1.0 unit/mL insulin aspart in infusion systems - using polypropylene infusion bags.
Croatian: Za intravensku primjenu, trebaju se koristiti infuzijski sustavi s aspart inzulinom u koncentraciji od 0,5 jedinica/ml do 1,0 jedinica/ml - u polipropilenskim infuzijskim vrećicama.
English: The following substances may reduce insulin requirement:
Croatian: Sljedeće tvari mogu smanjiti potrebu za inzulinom:
English: Time to maximum concentration and total insulin aspart exposure were all comparable between the abdomen, upper arm and the thigh.
Croatian: Vrijeme do maksimalne koncentracije i ukupna izloženost aspart inzulinu bili su usporedivi za abdomen, nadlakticu i bedro.
English: The onset of exposure in a CSII setting (time to reach maximum concentration) was 26 minutes shorter with Fiasp compared to NovoRapid resulting in approximately three times as much insulin available during the first 30 minutes (Figure 2).
Croatian: Nastup izloženosti uz primjenu putem KSII-ja (vrijeme do postizanja maksimalne koncentracije) bilo je 26 minuta kraće s lijekom Fiasp u usporedbi s lijekom NovoRapid, što je rezultiralo s otprilike tri puta više dostupnog inzulina tijekom prvih 30 minuta (Slika 2).
English: Insulins, including insulin aspart, the active ingredient in Fiasp, exert their specific action through binding to insulin receptors.
Croatian: Inzulini, uključujući i aspart inzulin, aktivni sastojak lijeka Fiasp, specifično djeluju vezivanjem na receptore inzulina.
English: The daily dose should be based on your blood sugar level at mealtimes and bedtime from the previous day.
Croatian: Dnevna doza treba se temeljiti na Vašoj razini šećera u krvi u vrijeme obroka i prije spavanja od prethodnog dana.
English: • Check the name and strength on the label of the cartridge (Penfill) to make sure it is Fiasp.
Croatian: • Provjerite naziv i jačinu na naljepnici uloška (Penfill) da biste bili sigurno kako sadrži Fiasp.
English: Pack sizes of 1 (with and without needles) pre-filled pen, 5 (without needles) pre-filled pens and multipack containing 10 (2 packs of 5) (without needles) pre-filled pens.
Croatian: Veličine pakiranja od 1 (sa ili bez igala) napunjene brizgalice, 5 (bez igala) napunjenih brizgalica i višestruko pakiranje koje sadrži 10 (2 pakiranja od 5) (bez igala) napunjenih brizgalica.
English: Observed rate of severe or BG confirmed hypoglycaemiaB per patient year of exposure (percentage of patients)
Croatian: Zabilježena stopa teške ili GK potvrđene hipoglikemijeB po bolesnik godini izloženosti (postotak bolesnika)
English: Continuous rotation of the injection site within the particular injection area may help to reduce the risk of developing these reactions.
Croatian: Neprestano mijenjanje mjesta injiciranja unutar određenog područja u kojem se injicira može pomoći umanjiti rizik od razvoja takvih reakcija.
English: The total insulin exposure was comparable between Fiasp and NovoRapid.
Croatian: Ukupna izloženost inzulinu bila je usporediva između lijekova Fiasp i NovoRapid.
English: These are uncommon and may affect up to 1 in 100 people.
Croatian: One su manje česte te se mogu javiti u do 1 na 100 osoba.
English: This can only be given by someone who knows how to use it.
Croatian: Injekciju može dati jedino osoba koja zna kako je primijeniti.
English: This is because the dosing or timing of your insulin injections, food or exercise may need to be changed.
Croatian: To je stoga što će možda biti potrebno promijeniti dozu i vrijeme primjene injekcija inzulina, prehranu ili tjelovježbu.
English: Fiasp starts to lower blood sugar faster compared to other mealtime insulins.
Croatian: Fiasp počinje snižavati šećer u krvi brže u usporedbi s ostalim inzulinima koji se uzimaju uz obrok.
English: This medicine is only suitable for injection under the skin (subcutaneous injection).
Croatian: Ovaj lijek je prikladan samo za ubrizgavanje pod kožu (supkutana injekcija).
English: • you experience difficulty in breathing
Croatian: • otežano dišete
English: • growth hormone - for growth hormone deficiency
Croatian: • hormon rasta - za nedostatak hormona rasta
English: Do not use Fiasp
Croatian: Nemojte primjenjivati Fiasp
English: Unit No adjustment
Croatian: Nema prilagodbe
English: The total glucose-lowering effect and maximum (GIRmax) glucose-lowering effect were comparable between Fiasp and NovoRapid.
Croatian: Ukupan učinak snižavanja glukoze i maksimalan (GIRmax) učinak snižavanja glukoze između lijekova Fiasp i NovoRapid bili su usporedivi.
English: In a 2-week cross-over trial, Fiasp showed a greater postmeal glucose-lowering effect after a standardised meal test with regard to 1-hour and 2-hour postmeal glucose response (treatment difference: -0.50 mmol/L [-1.07; 0.07]95% CI and -0.99 mmol/L [-1.95; -0.03]95% CI), respectively compared to NovoRapid in a CSII setting.
Croatian: U 2-tjednom ukriženom ispitivanju, Fiasp je pokazao veći učinak snižavanja glukoze nakon obroka nakon testa sa standardiziranim obrokom u odnosu na odgovor glukoze 1 i 2 sata nakon obroka (razlika u liječenju: -0,50 mmol/l [-1,07; 0,07]95% CI odnosno -0,99 mmol/l [-1,95; -0,03]95% CI), u usporedbi s lijekom NovoRapid uz primjenu putem KSII-ja.
English: The initial absorption rate was slower with increasing BMI while the total exposure was similar across different BMI levels.
Croatian: Početna brzina apsorpcije bila je niža kako je ITM bio veći, a ukupna izloženost bila je slična za različite razine ITM-a.
English: • if the cartridge or the reusable pen you are using is damaged.
Croatian: • ako su uložak ili brizgalica za višekratnu uporabu koji koristite oštećeni.
English: See section 4 under ‘High blood sugar'.
Croatian: Pogledajte dio 4 pod „Visoka razina šećera u krvi“.
English: • other medicines for diabetes (oral and injectable)
Croatian: • druge lijekove za liječenje šećerne bolesti (za primjenu kroz usta ili injiciranje)
English: • if you have trouble with your kidneys or liver, or with your adrenal, pituitary or thyroid glands.
Croatian: • ako imate poteškoća s bubrezima ili jetrom, ili s nadbubrežnom žlijezdom, hipofizom ili štitnjačom.
English: Do not touch the dose counter with your fingers.
Croatian: Nemojte prstima dodirivati brojčanik doze.
English: Continuous subcutaneous insulin infusion (CSII)
Croatian: Kontinuirana supkutana inzulinska infuzija (KSII)
English: In children (6-11 years) and adolescents (12-18 years) Fiasp showed, an earlier onset of exposure and a higher early insulin exposure whilst maintaining a similar total exposure and maximum concentration compared to NovoRapid.
Croatian: U usporedbi s lijekom NovoRapid, u djece (6-11 godina) i adolescenata (12-18 godina) Fiasp je pokazao raniji nastup izloženosti i veću ranu izloženost inzulinu, pri čemu se održala slična ukupna izloženost i maksimalna koncentracija.
English: Fiasp administered at mealtime was non-inferior to NovoRapid in reducing HbA1c, and the improvement in HbA1c was statistically significant in favour of Fiasp.
Croatian: Kada je Fiasp bio primijenjen uz obrok, bio je neinferiroran naspram lijeka NovoRapid u snižavanju HbA1c, a poboljšanje HbA1c statistički je značajno išlo u korist lijeka Fiasp.
English: Patients administering Fiasp by CSII must be trained to administer insulin by injection and have alternate insulin therapy available in case of pump failure.
Croatian: Bolesnici koji primjenjuju Fiasp putem KSII-ja moraju biti upućeni kako primijeniti inzulin injekcijom i imati na raspolaganju neku drugu inzulinsku terapiju za slučaj neispravnosti inzulinske pumpe.
English: After first opening or if carried as a spare: You can carry your vial with you and keep it at room temperature (not above 30°C) or in a refrigerator (2°C-8°C) for up to 4 weeks (including time in a pump reservoir).
Croatian: Nakon prvog otvaranja ili kad se lijek nosi kao rezervni: Svoju bočicu možete nositi sa sobom i čuvati na sobnoj temperaturi (ne iznad 30°C) ili u hladnjaku (2°C-8°C) do najviše 4 tjedna (uključujući vrijeme čuvanja u spremniku pumpe).
English: Always remove the needle from your pen after each injection and store your pen without the needle attached.
Croatian: Nakon svakog injiciranja uvijek skinite iglu s brizgalice, a potom spremite brizgalicu bez nataknute igle.
English: The infusion set (tubing and cannula) should be changed in accordance with the instructions in the product information supplied with the infusion set.
Croatian: Infuzijski set (cjevčica i kanila) treba mijenjati u skladu s uputama za uporabu koje su priložene uz infuzijski set.
English: Hypoglycaemia may occur earlier after an injection/infusion when compared to other mealtime insulins due to the earlier onset of action of Fiasp (see section 5.1).
Croatian: Hipoglikemija može nastupiti ranije nakon davanja injekcije/infuzije u usporedbi s drugim inzulinima koji se uzimaju uz obrok zbog bržeg početka djelovanja lijeka Fiasp (vidjeti dio 5.1)
English: This is particularly important in those who have reduced or absent awareness of the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia.
Croatian: To je osobito važno u osoba u kojih su upozoravajući simptomi hipoglikemije slabije izraženi ili izostaju te u osoba s učestalim epizodama hipoglikemije.
English: Examples
Croatian: Primjeri
English: (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to
Croatian: Kategorije učestalosti definirane su na sljedeći način: vrlo često (≥1/10); često (≥1/100 i <1/10); manje često (≥1/1000 i <1/100); rijetko (≥1/10 000 i <1/1000); vrlo rijetko (<1/10 000) i nepoznato (ne može se procijeniti iz dostupnih podataka).
English: • Always keep spare cartridges of Fiasp.
Croatian: • Uvijek trebate imati rezervne uloške lijeka Fiasp.
English: The efficacy and safety of Fiasp have been studied in a 1:1:1 randomised active controlled clinical trial in children and adolescents with type 1 diabetes, aged 1 to 18 years, for a period of 26 weeks (N=777).
Croatian: Djelotvornost i sigurnost lijeka Fiasp ispitivale su se tijekom 26 tjedana u randomiziranom (u omjeru 1:1:1), aktivnim lijekom kontroliranom kliničkom ispitivanju provedenom u djece i adolescenata sa šećernom bolešću tipa 1 u dobi od 1 do 18 godina (N=777).
English: Total and maximum glucose-lowering effect of Fiasp increase linearly with increasing dose within the therapeutic dose range.
Croatian: Ukupan i maksimalan učinak snižavanja glukoze lijeka Fiasp linearno se povećavaju s povećavanjem doze unutar terapijskog raspona doze.
English: They may increase or decrease your blood sugar level.
Croatian: Oba ta lijeka mogu povećati ili smanjiti razinu šećera u krvi.
English: Fiasp is a mealtime insulin with a fast-acting blood sugar lowering effect.
Croatian: Fiasp je inzulin koji se uzima uz obrok s brzodjelujućim učinkom snižavanja šećera u krvi.
English: Always keep the cap on the pen when you are not using it in order to protect from light.
Croatian: Uvijek držite zatvarač na brizgalici kad je ne koristite, radi zaštite od svjetlosti.
English: In patients with renal or hepatic impairment, glucose monitoring should be intensified and the dose adjusted on an individual basis (see section 5.2).
Croatian: U bolesnika s oštećenjem bubrega ili jetre treba pojačano pratiti razine glukoze te individualno prilagoditi dozu (vidjeti dio 5.2).
English: Glucose must be given intravenously if the patient does not respond to glucagon within 10 to 15 minutes.
Croatian: Ako bolesnik ne reagira na glukagon 10 do 15 minuta nakon primjene, mora se intravenski primijeniti glukoza.
English: Changing where you inject each time may reduce the risk of developing these skin changes.
Croatian: Promjena mjesta injiciranja kod svake injekcije može umanjiti rizik od takvih promjena na koži.
English: Dose adjustment may be considered daily based on self-measured plasma glucose (SMPG) on the previous day(s) according to Table 1.
Croatian: Može se razmatrati dnevna prilagodba doze na temelju glukoze u plazmi koju je bolesnik samostalno izmjerio prethodnog(ih) dana u skladu s Tablicom 1.
English: • When you fill a new reservoir, do not leave large air bubbles in either the syringe or the tubing.
Croatian: • Kad punite novi spremnik, provjerite da u štrcaljki i cjevčici nisu ostali veći mjehurići zraka.
English: If you forget to use your insulin your blood sugar may get too high (hyperglycaemia).
Croatian: Ako ste zaboravili primijeniti svoj inzulin, razina šećera u krvi može se previše povisiti (hiperglikemija).
English: This medicinal product contains less than 1 mmol sodium (23 mg) per dose i.e. essentially ‘sodiumfree'.
Croatian: Ovaj lijek sadrži manje od 1 mmol (23 mg) natrija po dozi, tj. zanemarive količine natrija.
English: Fiasp 100 units/mL solution for injection in cartridge After first opening or carried as a spare, the medicinal product may be stored for a maximum of 4 weeks.
Croatian: Fiasp 100 jedinica/ml otopina za injekciju u ulošku Nakon prvog otvaranja ili kad se lijek nosi kao rezervni, lijek se može čuvati najviše 4 tjedna.
English: In patients using CSII (N=261): Infusion site reactions (including redness, inflammation, irritation, pain, bruising and itching) were reported in patients treated with Fiasp (10.0% vs. 8.3% in comparator).
Croatian: U bolesnika koji primjenjuju KSII (N=261): reakcije na mjestu infuzije (uključujući crvenilo, upalu, iritaciju, bol, modrice i svrbež) prijavljene su u bolesnika liječenih lijekom Fiasp (10,0% naspram 8,3% za komparator).
English: Do not refrigerate.
Croatian: Ne odlagati u hladnjak.
English: If you use too much insulin your blood sugar may get too low (hypoglycaemia), see advice in section 4 under ‘Low blood sugar'.
Croatian: Ako primijenite previše inzulina, razina šećera u krvi može se previše sniziti (hipoglikemija), pogledajte savjete u dijelu 4 pod „Niska razina šećera u krvi“.
English: Hypersensitivity Anaphylactic reactions
Croatian: Preosjetljivost Anafilaktičke reakcije
English: The estimated odds of achieving HbA1c < 7% were statistically significantly greater with mealtime Fiasp than with mealtime NovoRapid (odds ratio: 1.47 [1.02; 2.13]95% CI).
Croatian: Procijenjeni izgledi za postizanje HbA1c <7% statistički su značajno veći s lijekom Fiasp uz obrok nego s lijekom NovoRapid uz obrok (omjer izgleda: 1,47 [1,02; 2,13]95% CI).
English: B Severe hypoglycaemia (episode requiring assistance of another person) or blood glucose (BG) confirmed hypoglycaemia defined as episodes confirmed by plasma glucose < 3.1 mmol/L irrespective of symptoms C The difference is for Fiasp mealtime - NovoRapid mealtime
Croatian: B Teška hipoglikemija (epizoda u kojoj je potrebna pomoć druge osobe) ili hipoglikemija potvrđena izmjerenim vrijednostima glukoze u krvi (GK) definirane kao epizode potvrđene glukozom u plazmi <3,1 mmol/l bez obzira na simptome C Razlika za Fiasp uz obrok - NovoRapid uz obrok
English: Skin reactions: Signs of allergy on the skin such as eczema, rash, itching, hives and dermatitis may occur.
Croatian: Reakcije na koži: Na koži se mogu pojaviti znakovi alergije poput ekcema, osipa, svrbeža, koprivnjače i dermatitisa.
English: Table 1 Dose adjustment SMPG (see above)
Croatian: Tablica 1 Prilagodba doze Samostalno izmjerena glukoza u plazmi (vidjeti gore)
English: Can be stored in the refrigerator (2°C-8°C).
Croatian: Može se čuvati u hladnjaku (2°C-8°C).
English: • Make sure you can see the dose counter.
Croatian: • Provjerite vidite li brojčanik doze.
English: Intravenous use
Croatian: Intravenska primjena
English: • Always carry an extra pen and new needles with you, in case of loss or damage.
Croatian: • Uvijek sa sobom nosite rezervnu brizgalicu i nove igle za slučaj da izgubite ili oštetite onu koju trenutno koristite.
English: If so, the full dose will not be delivered, and you should increase the frequency of checking your blood sugar level.
Croatian: nije primijenjena cijela doza i trebate češće kontrolirati razinu šećera u krvi.
English: Your blood sugar level may rise (hyperglycaemia) if you take:
Croatian: Razina šećera u krvi može porasti (hiperglikemija) ako uzimate:
English: Onset and early insulin exposure of Fiasp was similar in children and adolescents to that in adults.
Croatian: Nastup i rana izloženost inzulinu lijeka Fiasp u djece i adolescenata bili su slični onima u odraslih.
English: After administration of Fiasp, the fast onset of appearance is maintained regardless of injection site.
Croatian: Nakon primjene lijeka Fiasp brz nastup pojave u krvotoku održava se neovisno o mjestu injiciranja.
English: If you are blind or have poor eyesight and cannot read the dose counter on the pen, do not use this pen without help.
Croatian: Ako ste slijepi ili slabo vidite i ne možete pročitati brojčanik doze na brizgalici, ne koristite ovu brizgalicu bez tuđe pomoći.
English: Doses and timing of concurrent intermediate-acting or long-acting insulin medicinal products or other concomitant antidiabetic treatment may need to be adjusted.
Croatian: Možda će se trebati prilagoditi doze i vrijeme primjene istodobno primjenjivanih srednjedugodjelujućih ili dugodjelujućih inzulinskih pripravaka ili ostalih istodobno primjenjivanih antidijabetičkih terapija.
English: Patients in the Fiasp mealtime arm included 16 children aged 2-5 years, 100 children aged 6-11 years and 144 adolescents aged 12-17 years.
Croatian: Skupina koja je primala Fiasp uz obrok uključivala je 16 djece u dobi od 2 do 5 godina, 100 djece u dobi od 6 do 11 godina i 144 adolescenta u dobi od 12 do 17 godina.
English: D The difference is for Fiasp postmeal - NovoRapid mealtime
Croatian: D Razlika za Fiasp nakon obroka - NovoRapid uz obrok
English: Clear, colourless, aqueous solution.
Croatian: Bistra, bezbojna, vodena otopina.
English: No statistical significant difference was shown between postmeal Fiasp and mealtime NovoRapid.
Croatian: Nije pokazana statistički značajna razlika između lijeka Fiasp nakon obroka i lijeka NovoRapid uz obrok.
English: Fiasp showed a comparable earlier onset of exposure and a higher early insulin exposure whilst maintaining a similar total exposure and maximum concentration compared to NovoRapid for both females and male patients with type 1 diabetes.
Croatian: Fiasp je pokazao usporediv raniji nastup izloženosti i veću ranu izloženost inzulinu, pri čemu se održala slična ukupna izloženost i maksimalna koncentracija u usporedbi s lijekom NovoRapid za ženske i muške bolesnike sa šećernom bolešću tipa 1.
English: • your blood sugar got so low that you passed out
Croatian: • Vam se razina šećera u krvi toliko snizila da ste izgubili svijest
English: Now turn over for information on how to use your FlexTouch.
Croatian: Sada okrenite stranicu za informacije kako koristiti FlexTouch.
English: Hypoglycaemia may occur earlier after an injection/infusion of Fiasp compared to other mealtime insulins due to the earlier onset of action.
Croatian: Hipoglikemija može nastupiti ranije nakon primjene injekcije/infuzije lijeka Fiasp u usporedbi s drugim inzulinima koji se uzimaju uz obrok zbog bržeg početka djelovanja.
English: Figure 2 Mean insulin profiles in patients with type 1 diabetes in a CSII setting (0-5 hours) corrected for basal insulin infusion
Croatian: Slika 2 Profili srednje koncentracije inzulina u bolesnika sa šećernom bolešću tipa 1 uz primjenu putem KSII-ja (0-5 sati) korigirani za infuziju bazalnog inzulina Distribucija
English: • Changing of the infusion set (tubing and needle) must be done according to the instructions in the product information supplied with the infusion set.
Croatian: • Zamjena infuzijskog seta (cjevčice i igle) mora se obaviti prema uputama za uporabu priloženim uz infuzijski set.
English: After first opening or if carried as a spare: You can carry your pre-filled pen (FlexTouch) with you and keep it at room temperature (not above 30°C) or in a refrigerator (2°C-8°C) for up to 4 weeks.
Croatian: Nakon prvog otvaranja ili kad se lijek nosi kao rezervni: Svoju napunjenu brizgalicu (FlexTouch) možete nositi sa sobom i čuvati na sobnoj temperaturi (ne iznad 30°C) ili u hladnjaku (2°C-8°C) do najviše 4 tjedna.
English: Allergic skin manifestations
Croatian: Alergijske reakcije na koži
English: Receptor-bound insulin lowers blood glucose by facilitating cellular uptake of glucose into skeletal muscle and adipose tissue and by inhibiting the output of glucose from the liver.
Croatian: Inzulin vezan na receptore snižava razinu glukoze u krvi olakšavanjem unosa glukoze u stanice skeletnih mišića i masno tkivo, te inhibicijom otpuštanja glukoze iz jetre.
English: • If 0 does not appear in the dose counter after continuously pressing the dose button, you may have used a blocked or damaged needle.
Croatian: • Ako se na brojčaniku doze ne pojavi 0 nakon neprestanog pritiskanja gumba za doziranje,
English: What to do if you get low blood sugar
Croatian: Što učiniti ako osjetite nisku razinu šećera u krvi
English: • High blood sugar (hyperglycaemia) - If your blood sugar is too high, follow the guidance for high blood sugar in section 4 ‘Possible side effects'.
Croatian: • Visoka razina šećera u krvi (hiperglikemija) - ako je razina šećera u Vašoj krvi previsoka, slijedite upute za visoku razinu šećera u krvi u dijelu 4 „Moguće nuspojave“.
English: Before you use Fiasp for the first time, your doctor or nurse will show you how to use it.
Croatian: Prije prve uporabe lijeka Fiasp, Vaš liječnik ili medicinska sestra pokazat će Vam kako ga primijeniti.
English: • feeling unusually tired, weak and sleepy
Croatian: • osjećaj neuobičajenog umora, slabosti i pospanosti
English: Multipack: 10 (2 packs of 5 x 3 mL) pre-filled pens
Croatian: Višestruko pakiranje: 10 (2 pakiranja od 5 x 3 ml) napunjenih brizgalica
English: • Do not wash, soak or lubricate your pen.
Croatian: • Nemojte prati, namakati ni podmazivati brizgalicu.
English: EU/1/16/1160/001 1 pen of 3 mL EU/1/16/1160/002 1 pen of 3 mL and 7 NovoFine Plus needles EU/1/16/1160/003 1 pen of 3 mL and 7 NovoFine needles EU/1/16/1160/004 1 pen of 3 mL and 7 NovoTwist needles EU/1/16/1160/005 5 pens of 3 mL
Croatian: EU/1/16/1160/001 1 brizgalica od 3 ml EU/1/16/1160/002 1 brizgalica od 3 ml i 7 igala NovoFine Plus EU/1/16/1160/003 1 brizgalica od 3 ml i 7 igala NovoFine EU/1/16/1160/004 1 brizgalica od 3 ml i 7 igala NovoTwist EU/1/16/1160/005 5 brizgalica od 3 ml
English: If you do not check the flow, you may get too little insulin or no insulin at all.
Croatian: Ako ne provjerite protok, možete primijeniti premalo ili nimalo inzulina.
English: Always check the flow before you inject.
Croatian: Uvijek provjerite protok prije injiciranja.
English: Insulin aspart concentration (pmol/L)
Croatian: Koncentracija aspart inzulina (pmol/l)
English: Rough handling or misuse may cause inaccurate dosing, which can lead to high or low blood sugar levels.
Croatian: Grubo rukovanje ili nepravilna uporaba mogu uzrokovati pogrešno doziranje, što može dovesti do previsoke ili preniske razine šećera u krvi.